MD Anderson and Hitachi to collaborate in research for treatment of oropharyngeal cancer of the head and neck

The University of Texas MD Anderson Cancer Centre and Hitachi Healthcare Americas Corporation, have announced that they have entered into an agreement to collaborate on research for a unique randomised clinical trial comparing the outcomes and side-effects of intensity-modulated proton beam therapy versus intensity-modulated photon therapy for the treatment of oropharyngeal cancer of the head and neck.
EurekAlert